HIMS
UTHR icon

Hager Investment Management Services’s United Therapeutics UTHR Stock Holding History

Hager Investment Management Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42K Buy
10
+1
+11% +$563 ﹤0.01% 281
2026
Q1 		$5.34K Hold
9
– – ﹤0.01% 260
2025
Q4 		$4.38K Buy
+9
New +$4.19K ﹤0.01% 262

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hager Investment Management Services's UTHR Position: Q2 2026 in Review

Hager Investment Management Services increased its United Therapeutics (UTHR) stake by 11% in Q2 2026, buying an estimated $563 and bringing the position to 10 shares worth $5.42K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Hager Investment Management Services first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Hager Investment Management Services held 10 shares of United Therapeutics worth $5.42K as of Q2 2026.
  • Hager Investment Management Services bought 1 United Therapeutics share in Q2 2026, an estimated $563.
  • United Therapeutics made up ﹤0.01% of Hager Investment Management Services's portfolio in Q2 2026, its #281 holding.
  • Hager Investment Management Services first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.